Journal of Cardiology Cases最新文献

{"title":"Left main compression syndrome caused by pulmonary hypertension due to peripheral pulmonary artery stenosis complicated with moyamoya disease","authors":"Sei Matsuo MD,&nbsp;Kazuyuki Ozaki MD, FJCC,&nbsp;Takeshi Kashimura MD,&nbsp;Yuji Matsuo MD,&nbsp;Tsugumi Takayama MD,&nbsp;Makoto Hoyano MD,&nbsp;Takao Yanagawa MD,&nbsp;Takayuki Inomata MD, FJCC","doi":"10.1016/j.jccase.2024.09.006","DOIUrl":"10.1016/j.jccase.2024.09.006","url":null,"abstract":"<div><div>Left main compression syndrome (LMCS) is a disease in which the ostium of the left main coronary artery is compressed between a dilated pulmonary artery and the sinus of Valsalva associated with pulmonary hypertension (PH). The major etiology of LMCS is secondary PH due to congenital heart disease. However, no reports exist regarding LMCS caused by PH due to peripheral pulmonary artery stenosis complicated with moyamoya disease (MMD). We report a case of LMCS caused by PH due to peripheral pulmonary artery stenosis complicated with MMD in a 41-year-old woman who was treated with percutaneous coronary intervention.</div></div><div><h3>Learning objective</h3><div>Left main compression syndrome (LMCS) is a condition in which the main trunk of the left coronary artery is compressed between the dilated pulmonary artery and aorta due to pulmonary hypertension. This paper reports the first case of LMCS due to peripheral pulmonary artery stenosis complicated with moyamoya disease.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"31 2","pages":"Pages 29-34"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143150251","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Comprehensive cardiac rehabilitation utilized to support patients with heart failure for balancing treatment and work: A case report","authors":"Kazufumi Kitagaki (PhD) ,&nbsp;Yuji Hongo (MSc) ,&nbsp;Rie Futai (PhD) ,&nbsp;Takeshi Hasegawa (RPT) ,&nbsp;Tatsuyoshi Azuma (BSc) ,&nbsp;Hiroshi Morikawa (BSc) ,&nbsp;Hazuki Koizumi (Ns) ,&nbsp;Takuya Kiyohara (MD) ,&nbsp;Hisashi Shimoyama (PhD)","doi":"10.1016/j.jccase.2024.10.003","DOIUrl":"10.1016/j.jccase.2024.10.003","url":null,"abstract":"<div><div>A 47-year-old woman with exertional dyspnea was admitted to our hospital. Echocardiography revealed congestive heart failure (HF), with reduced left ventricular ejection fraction (13 %) and elevated brain natriuretic peptide levels (877 pg/mL). The patient underwent medical therapy and comprehensive cardiac rehabilitation (CR). At discharge, the oxygen uptake at anaerobic threshold (AT) was 13.1 mL/kg/min. Outpatient CR consisted of exercise therapy, patient education, and home activity intensity instructions with pulse rate (PR) management using a wearable device. We instructed that activity intensity at home should not exceed the PR at AT. Two months after discharge, the patient's condition was stable, and she was compliant with activity intensity restrictions; therefore, she was allowed to return to work twice a week for 5 h of light work weekly, which was gradually increased. We continued to monitor the PR with wearable devices to ensure compliance with work intensity. Five months after discharge, she achieved a return to work four times a week for 8 h without exacerbation of HF symptoms. The workplace was receptive to the suggestions of the CR team regarding workplace conditions, safe working hours, and frequency, and the patient successfully returned to work, achieving a balance between treatment and work.</div></div><div><h3>Learning objective</h3><div>The use of comprehensive cardiac rehabilitation is recommended for the return to work by patients with heart failure. However, specific measures to manage activity intensity for return to work have not been considered fully. The strategy that we adopted involved a combination of comprehensive cardiac rehabilitation and the use of wearable devices for guided work intensity management, allowing for a balance between treatment and work responsibilities.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"31 2","pages":"Pages 35-38"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143150252","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Effectiveness of surgery and chemotherapy with immune checkpoint inhibitor for cardiac metastatic squamous cell carcinoma of unknown primary","authors":"Akito Kuwano MD ,&nbsp;Masaru Yoshikai MD, PhD ,&nbsp;Satoshi Ohtsubo MD, PhD ,&nbsp;Kiyokazu Koga MD, PhD ,&nbsp;Nozomi Yoshida MD ,&nbsp;Naoyo Nishida MD, PhD","doi":"10.1016/j.jccase.2024.10.002","DOIUrl":"10.1016/j.jccase.2024.10.002","url":null,"abstract":"<div><div>We present a case of squamous cell carcinoma of unknown primary (SCCUP) with metastasis to the right ventricle (RV) successfully treated through surgical resection and postoperative chemotherapy with an immune checkpoint inhibitor (ICI). A 50-year-old woman presented with dyspnea, prompting transthoracic echocardiography that revealed a mobile, irregular RV mass measuring 40 × 32 mm. Contrast-enhanced computed tomography (CT) revealed masses in the RV and the right pulmonary artery, which was totally occluded. Emergency surgical resection of both masses was performed to avoid sudden death. Histopathological analysis confirmed squamous cell carcinoma; however, the primary origin of the masses remained unidentified despite extensive evaluations, including positron emission tomography-CT. The final diagnosis was SCCUP. Immunohistochemistry indicated positive programmed cell death ligand 1, and postoperative chemotherapy with an ICI was administered. One year post-surgery, the patient remains healthy with no sign of recurrence.</div></div><div><h3>Learning objective</h3><div>This case shows the treatment of squamous cell carcinoma of unknown primary (SCCUP) with cardiac metastasis through emergency surgery and postoperative immunotherapy. Despite the poor prognosis associated with cardiac metastatic malignant tumors and the lack of established treatment guidelines, this case highlights the potential benefits of surgical intervention and the efficacy of immunotherapy in managing cardiac metastatic SCCUP, with the patient remaining with no recurrence one-year post-surgery.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"31 2","pages":"Pages 39-41"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143149310","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Late stent thrombosis six months after ultrathin-strut covered stent implantation in lesion with calcified nodule","authors":"Naoko Higashino MD,&nbsp;Takayuki Ishihara MD,&nbsp;Takuya Tsujimura MD,&nbsp;Yosuke Hata MD,&nbsp;Sho Nakao MD,&nbsp;Masaya Kusuda MD,&nbsp;Toshiaki Mano MD, PhD","doi":"10.1016/j.jccase.2024.11.002","DOIUrl":"10.1016/j.jccase.2024.11.002","url":null,"abstract":"<div><div>A 72-year-old woman undergoing hemodialysis presented with effort angina pectoris due to severe stenosis with calcified nodules in the right coronary artery. Percutaneous coronary intervention was performed using an excimer laser coronary angioplasty and an ultrathin-strut covered stent (CS) was implanted due to coronary perforation. An additional durable-polymer everolimus-eluting stent (DP-EES) was implanted because of protrusions in the proximal edge of the CS. However, late stent thrombosis occurred six months after ultrathin-strut covered stent implantation for a calcified nodule. After thrombus aspiration, intravascular imaging analyses revealed that the struts within the CS were fully covered with thick neointimal hyperplasia. In contrast, half of the struts in the DP-EES were uncovered and some struts were malapposed. In this case, we speculated that the cause of the current late stent thrombosis was dispersion of the thrombi formed at the uncovered with malapposed sites in the DP-EES into a severe stenosis caused by neointimal hyperplasia in the CS. Neointimal hyperplasia occurs at the edge of the CS, a CS should be implanted locating its edge on the site with less plaque.</div></div><div><h3>Learning objectives</h3><div><ul><li><span>•</span><span><div>To evaluate the mechanism of late stent thrombosis after ultrathin strut-covered stent implantation for lesions with calcified nodules.</div></span></li><li><span>•</span><span><div>To discuss the optimal covered stent placement locating its edge on the site with less plaque.</div></span></li><li><span>•</span><span><div>To recognize that introduction of an ultrathin-strut covered stent for lesions with calcified nodules requires careful consideration.</div></span></li></ul></div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"31 2","pages":"Pages 46-48"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143149311","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impaired myocardial perfusion and myocardial inflammation of acute myopericarditis associated with COVID-19","authors":"Shiro Miura MD, PhD ,&nbsp;Kisaki Amemiya MD, PhD ,&nbsp;Atsutaka Okizaki MD, PhD ,&nbsp;Osamu Manabe MD, PhD ,&nbsp;Shingo Tsujinaga MD, PhD ,&nbsp;Chihoko Miyazaki MD, PhD ,&nbsp;Yoshihiko Ikeda MD, PhD ,&nbsp;Kinta Hatakeyama MD, PhD ,&nbsp;Shuji Takahashi MD, PhD ,&nbsp;Takehiro Yamashita MD, PhD","doi":"10.1016/j.jccase.2024.09.008","DOIUrl":"10.1016/j.jccase.2024.09.008","url":null,"abstract":"<div><div>Myocarditis and pericarditis, or myopericarditis, is a rare, albeit life-threatening, cardiac complication of coronavirus disease 2019 (COVID-19). Although most patients recover from myocardial inflammation within weeks of the acute infection, there are concerns about acute and long-term myocardial injury. Coronary microvascular dysfunction and myocardial inflammation in the affected myocardium might be key factors in developing acute COVID-19-associated myopericarditis. In this case report, we describe a 38-year-old woman diagnosed with acute COVID-19-associated myopericarditis who was treated successfully. This case highlights the remarkable recovery in coronary microcirculation and myocardial inflammation assessed using multi-imaging modalities from the acute phase to 3-month follow-up using histopathological assessments.</div></div><div><h3>Learning objective</h3><div>Acute myopericarditis is one of the serious cardiac complications associated with severe acute respiratory syndrome coronavirus 2 infection, although an accurate diagnosis might be challenging. We emphasize a novel combination of magnetic resonance imaging and positron emission tomography focusing on serial changes in coronary microcirculation and myocardial inflammation from acute to recovery phases. Our findings may elucidate the pathophysiology of this entity at the micro and macro levels.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"31 1","pages":"Pages 12-16"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143015534","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cardiac rupture and toxic shock syndrome by invasive group a Streptococcus in a Fontan patient with Asplenia syndrome","authors":"Mamoru Muraoka MD ,&nbsp;Kenichi Tetsuhara MD, PhD ,&nbsp;Sayo Suzuki MD ,&nbsp;Kenichiro Yamamura MD, PhD ,&nbsp;Toshihide Nakano MD, PhD ,&nbsp;Sagano Onoyama MD, PhD ,&nbsp;Koichi Sagawa MD, PhD","doi":"10.1016/j.jccase.2024.09.009","DOIUrl":"10.1016/j.jccase.2024.09.009","url":null,"abstract":"<div><div>The incidence of invasive group A Streptococcus (iGAS) infection has been increasing across all age groups, including pediatric patients, and is associated with high mortality rates. Although iGAS infection leads to streptococcal toxic shock syndrome and necrotizing soft tissue infections, iGAS-associated infective endocarditis (IE) is rare. Here, we report a case of iGAS-associated IE, streptococcal toxic shock syndrome, and pyomyositis that occurred after the Fontan procedure in a 7-year-old patient. Initial treatment included antibiotics and surgical intervention for pyomyositis. Despite her overall condition's improvement, persistent fever led to the discovery of IE. Furthermore, this patient developed cardiac rupture due to the progression of IE but was successfully rescued. No neurological complications occurred, and the patient was discharged without recurrence of infection. To our knowledge, this is the first case report of successful life-saving treatment for cardiac rupture due to IE caused by iGAS in a pediatric Fontan patient. This case suggests that iGAS infections in patients with complex congenital heart disease warrant a crucial search for complications of iGAS-associated IE.</div></div><div><h3>Learning objective</h3><div>The incidence of invasive group A Streptococcus (iGAS) infection is increasing globally. While infective endocarditis (IE) caused by iGAS is rare, the risk may be elevated among patients with complex congenital heart disease. This underscores the importance of searching for iGAS-associated IE and the need for treatment with consideration for exacerbation.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"31 1","pages":"Pages 24-28"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Complete atrial screw lead penetration and contralateral pneumothorax post-pacemaker implantation","authors":"Satoko Shiomi MD,&nbsp;Michifumi Tokuda MD, PhD,&nbsp;Hidenori Sato MD, PhD,&nbsp;Kenichi Tokutake MD, PhD,&nbsp;Seigo Yamashita MD, PhD,&nbsp;Michihiro Yoshimura MD, PhD, FJCC,&nbsp;Teiichi Yamane MD, PhD","doi":"10.1016/j.jccase.2024.09.002","DOIUrl":"10.1016/j.jccase.2024.09.002","url":null,"abstract":"<div><div>There are some reports of atrial screw-in lead perforation, but the entire lead body is rarely exposed outside the right atrium at an early stage of the procedure. A man in his 80s had undergone catheter ablation for atrial fibrillation (AF) and had recurrent AF and tachycardia-bradycardia syndrome with 8.8 s of sinus arrest, which caused presyncope. The day after the dual-chamber pacemaker was implanted, atrial screw-in lead perforation caused an elevated threshold, a right pneumothorax, bloody pleural effusion, and pneumomediastinum. A small right thoracotomy with thoracoscopy was performed. The lead that completely penetrated the right atrial appendage and was exposed was safely retracted into the heart and removed thoracoscopically. Early surgery is essential when complete lead perforation with elevated threshold is suspected.</div></div><div><h3>Learning objectives</h3><div><ul><li><span>1.</span><span><div>Perforation of the right atrium by the screw-in lead causes contralateral pneumothorax and chest hemorrhage.</div></span></li><li><span>2.</span><span><div>Elevated lead threshold suggests lead perforation outside the myocardium.</div></span></li><li><span>3.</span><span><div>Treatment was possible with a small right thoracotomy combined with thoracoscopy.</div></span></li></ul></div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"31 1","pages":"Pages 1-4"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143069603","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Alcohol septal ablation in drug-refractory hypertrophic obstructive cardiomyopathy patient with multiple comorbidities","authors":"Ryota Sato MD, PhD ,&nbsp;Atsushi Sakamoto MD, PhD ,&nbsp;Kenichiro Suwa MD, PhD ,&nbsp;Keisuke Iguchi MD, PhD ,&nbsp;Makoto Sano MD, PhD ,&nbsp;Keitaro Akita MD, PhD ,&nbsp;Terumori Satoh MD, PhD ,&nbsp;Hiroe Tsukui MD ,&nbsp;Takenori Ikoma MD, PhD ,&nbsp;Yuichiro Maekawa MD, PhD, FJCC","doi":"10.1016/j.jccase.2024.09.003","DOIUrl":"10.1016/j.jccase.2024.09.003","url":null,"abstract":"<div><div>Septal reduction therapy is an effective treatment for hypertrophic obstructive cardiomyopathy (HOCM). Alcohol septal ablation (ASA) is indicated for HOCM patients who are ineligible for surgical myectomy, but several tips exist for the management of high-risk patients with ASA. Here, we present a case of successful ASA in a HOCM patient with multiple comorbidities, including severe obesity, drug-refractory bronchial asthma, poorly controlled diabetes, and steroid-induced immunosuppression. Pre-procedural strict glycemic control, pre-treatment with corticosteroids for bronchospasm prevention, minimal puncture sites for device insertion, and myocardial contrast echocardiography-guided procedure contributed to the achievement of successful ASA. With careful periprocedural management, ASA is a safe and effective treatment option for drug-refractory HOCM, even in high-risk patients with multiple comorbidities.</div></div><div><h3>Learning objective</h3><div>Alcohol septal ablation can be a beneficial and safe treatment option for hypertrophic obstructive cardiomyopathy patients with multiple comorbidities, including severe obesity, drug-refractory bronchial asthma, poorly controlled diabetes, and steroid-induced immunosuppression. Detailed periprocedural management, including myocardial contrast echocardiography-guided procedure, is the key for achievement.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"31 1","pages":"Pages 5-8"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016207","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A surgical case of right ventricular outpouching","authors":"Tsukasa Miyatake MD, PhD ,&nbsp;Yuki Tanaka MD ,&nbsp;Koji Sato MD, PhD ,&nbsp;Noriyuki Otsuka MD, PhD ,&nbsp;Akihiko Yotsukura MD, PhD ,&nbsp;Noriyoshi Kato MD, PhD ,&nbsp;Masayuki Sakurai MD, PhD","doi":"10.1016/j.jccase.2024.09.007","DOIUrl":"10.1016/j.jccase.2024.09.007","url":null,"abstract":"<div><div>Outpouching of the heart ventricles, especially of the right ventricle, is rare. Here, we report the case of a 60-year-old male, referred to our institution with an outpouched structure at the right ventricular apex. The patient had no cardiac events. The outpouching was detected incidentally on computed tomography. The structure communicated with the right ventricle through a narrow pedicle. It did not contract, but showed dyskinetic movement with a thin wall. We safely resected it using off-pump coronary bypass apparatuses without cardiopulmonary bypass. Histopathological examination revealed muscular tissues only on the base of the structure, and certain parts of the wall were extremely thin. The treatment of ventricular outpouching, especially of the right ventricle, is controversial. The surgical indications could be decided by comparing the actual risk of rupture with that of surgery if we could accumulate the data from more cases.</div></div><div><h3>Learning objectives</h3><div><ul><li><span>1.</span><span><div>The terminology of heart ventricular outpouched structures is obscure and the structure presented in our patient may be termed a diverticulum, aneurysm, pseudoaneurysm, epicardial cyst, or an outpouching.</div></span></li><li><span>2.</span><span><div>Some right ventricular outpouchings can be resected safely using off-pump coronary bypass apparatuses without cardiopulmonary bypass.</div></span></li><li><span>3.</span><span><div>The surgical indications for right ventricular outpouching refer to those for left ventricular outpouching. More data are expected in the future.</div></span></li></ul></div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"31 1","pages":"Pages 17-19"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143016204","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Transcatheter aortic valve implantation: A feasible and a therapeutic procedure for cardiogenic shock in severe aortic stenosis","authors":"Georgios Chalikias MD, PhD,&nbsp;Dimitrios Stakos MD, PhD,&nbsp;Dimitrios Tziakas MD, PhD","doi":"10.1016/j.jccase.2024.09.001","DOIUrl":"10.1016/j.jccase.2024.09.001","url":null,"abstract":"<div><div>Transcatheter aortic valve implantation (TAVI) procedure is a well-established therapeutic measure for severe aortic stenosis with expanding indications. We present a case of a patient who had undergone a TAVI procedure during cardiopulmonary resuscitation on the grounds of cardiogenic shock.</div></div><div><h3>Learning objectives</h3><div>During the past decade, as platform and delivery technology regarding the implementation of transcatheter aortic valve implantation (TAVI) have improved, procedure indications expanded both to low and very high-risk patients. Patients presenting with cardiogenic shock on the grounds of severe aortic stenosis identifies yet another sub-group of patients that could benefit from TAVI.</div></div>","PeriodicalId":52092,"journal":{"name":"Journal of Cardiology Cases","volume":"31 1","pages":"Pages 9-11"},"PeriodicalIF":0.0,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143015535","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}